HOLMES EDWARD W 4
4 · TULARIK INC · Filed Aug 17, 2004
Insider Transaction Report
Form 4
TULARIK INCTLRK
HOLMES EDWARD W
Director
Transactions
- Disposition to Issuer
Stock Option (right to buy)
2004-08-13−10,000→ 0 totalExercise: $5.17Exp: 2013-04-22→ Common Stock (10,000 underlying) - Disposition to Issuer
Stock Option (right to buy)
2004-08-13−25,000→ 0 totalExercise: $7.09Exp: 2012-09-24→ Common Stock (25,000 underlying)
Footnotes (2)
- [F1]This option, which provided for vesting in equal annual installments over a four-year period until full vest on September 25, 2006, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 11,275 shares of Amgen common stock for $15.73 per share.
- [F2]This option, which provided for vesting in equal annual installments over a four-year period until full vest on April 23, 2007, was assumed by Amgen, Inc. in the merger and replaced with an option to purchase 4,510 shares of Amgen common stock for $11.47 per share.